Hoda Elkafas

929 total citations · 1 hit paper
16 papers, 553 citations indexed

About

Hoda Elkafas is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Immunology. According to data from OpenAlex, Hoda Elkafas has authored 16 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Reproductive Medicine, 9 papers in Obstetrics and Gynecology and 5 papers in Immunology. Recurrent topics in Hoda Elkafas's work include Endometriosis Research and Treatment (10 papers), Uterine Myomas and Treatments (9 papers) and Reproductive System and Pregnancy (4 papers). Hoda Elkafas is often cited by papers focused on Endometriosis Research and Treatment (10 papers), Uterine Myomas and Treatments (9 papers) and Reproductive System and Pregnancy (4 papers). Hoda Elkafas collaborates with scholars based in United States, Egypt and Poland. Hoda Elkafas's co-authors include Ayman Al‐Hendy, Mohamed Ali, Michał Ciebiera, Qiwei Yang, María Victoria Bariani, Thomas G. Boyer, Sahar Esfandyari, Nahed Ismail, Hang-Soo Park and Rishi Man Chugh and has published in prestigious journals such as Nature Communications, Endocrine Reviews and International Journal of Molecular Sciences.

In The Last Decade

Hoda Elkafas

16 papers receiving 547 citations

Hit Papers

Comprehensive Review of Uterine Fibroids: Developmental O... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hoda Elkafas United States 9 332 302 131 99 54 16 553
Virginia Foreste Italy 12 257 0.8× 103 0.3× 117 0.9× 97 1.0× 82 1.5× 22 445
Shuai Sun China 9 278 0.8× 106 0.4× 151 1.2× 178 1.8× 61 1.1× 19 444
Maria Teresa Schettino Italy 14 108 0.3× 134 0.4× 102 0.8× 78 0.8× 42 0.8× 45 501
Sebastian Franik Netherlands 13 542 1.6× 224 0.7× 98 0.7× 82 0.8× 308 5.7× 19 819
Valeria Stella Vanni Italy 16 561 1.7× 254 0.8× 94 0.7× 250 2.5× 386 7.1× 50 796
Claudio Gustavino Italy 10 152 0.5× 153 0.5× 33 0.3× 35 0.4× 45 0.8× 32 361
Shadi Eghbal‐Fard Iran 13 113 0.3× 193 0.6× 103 0.8× 363 3.7× 158 2.9× 16 574
Bárbara Yasmin Gueuvoghlanian‐Silva Brazil 11 197 0.6× 319 1.1× 42 0.3× 257 2.6× 74 1.4× 20 483
Nissim Arbib Israel 14 94 0.3× 219 0.7× 138 1.1× 31 0.3× 79 1.5× 39 501
Annalisa Tancredi Italy 10 60 0.2× 76 0.3× 127 1.0× 69 0.7× 61 1.1× 19 411

Countries citing papers authored by Hoda Elkafas

Since Specialization
Citations

This map shows the geographic impact of Hoda Elkafas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hoda Elkafas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hoda Elkafas more than expected).

Fields of papers citing papers by Hoda Elkafas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hoda Elkafas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hoda Elkafas. The network helps show where Hoda Elkafas may publish in the future.

Co-authorship network of co-authors of Hoda Elkafas

This figure shows the co-authorship network connecting the top 25 collaborators of Hoda Elkafas. A scholar is included among the top collaborators of Hoda Elkafas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hoda Elkafas. Hoda Elkafas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Elkafas, Hoda, et al.. (2024). Integrating leiomyoma genetics, epigenomics, and single-cell transcriptomics reveals causal genetic variants, genes, and cell types. Nature Communications. 15(1). 1169–1169. 7 indexed citations
2.
Elkafas, Hoda, et al.. (2023). Prevalence of Vancomycin-resistant enterococci (VRE) in Egypt (2010–2022): a systematic review and meta-analysis. Journal of the Egyptian Public Health Association. 98(1). 8–8. 12 indexed citations
3.
Kanmani, Paulraj, et al.. (2023). p120-Catenin suppresses NLRP3 inflammasome activation in macrophages. American Journal of Physiology-Lung Cellular and Molecular Physiology. 324(5). L596–L608. 4 indexed citations
4.
Chen, Xintong, Hoda Elkafas, Fidan Seker-Polat, et al.. (2023). Engineered MED12 mutations drive leiomyoma-like transcriptional and metabolic programs by altering the 3D genome compartmentalization. Nature Communications. 14(1). 4057–4057. 13 indexed citations
5.
Teymournejad, Omid, et al.. (2023). Hepatocyte-specific regulation of autophagy and inflammasome activation via MyD88 during lethal Ehrlichia infection. Frontiers in Immunology. 14. 1212167–1212167. 2 indexed citations
6.
Elkafas, Hoda, et al.. (2022). Gut and genital tract microbiomes: Dysbiosis and link to gynecological disorders. Frontiers in Cellular and Infection Microbiology. 12. 1059825–1059825. 56 indexed citations
7.
Elkafas, Hoda, et al.. (2021). Endocrine-Disrupting Chemicals and Vitamin D Deficiency in the Pathogenesis of Uterine Fibroids. PubMed. 5(2). 248–263. 8 indexed citations
8.
Yang, Qiwei, Michał Ciebiera, María Victoria Bariani, et al.. (2021). Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocrine Reviews. 43(4). 678–719. 193 indexed citations breakdown →
9.
Ciebiera, Michał, Sahar Esfandyari, Hoda Elkafas, et al.. (2021). Nutrition in Gynecological Diseases: Current Perspectives. Nutrients. 13(4). 1178–1178. 62 indexed citations
10.
Esfandyari, Sahar, Hoda Elkafas, Rishi Man Chugh, et al.. (2021). Exosomes as Biomarkers for Female Reproductive Diseases Diagnosis and Therapy. International Journal of Molecular Sciences. 22(4). 2165–2165. 103 indexed citations
11.
Elkafas, Hoda, María Victoria Bariani, Mohamed Ali, et al.. (2020). PRO-INFLAMMATORY AND IMMUNOSUPPRESSIVE ENVIRONMENT CONTRIBUTES TO THE DEVELOPMENT AND PROGRESSION OF UTERINE FIBROIDS. Fertility and Sterility. 114(3). e87–e87. 6 indexed citations
12.
Elkafas, Hoda, Mohamed Ali, Rehab Kamel, et al.. (2020). Vitamin D3 Ameliorates DNA Damage Caused by Developmental Exposure to Endocrine Disruptors in the Uterine Myometrial Stem Cells of Eker Rats. Cells. 9(6). 1459–1459. 34 indexed citations
13.
Elkafas, Hoda, et al.. (2019). Targeting activated pro-inflammatory pathway in primed myometrial stem cells with vitamin D3 and Paricalcitol. Fertility and Sterility. 112(3). e100–e101. 3 indexed citations
14.
Elhusseini, Heba, Hoda Elkafas, Sunil K. Halder, et al.. (2018). Diet-induced vitamin D deficiency triggers inflammation and DNA damage profile in murine myometrium. International Journal of Women s Health. Volume 10. 503–514. 30 indexed citations
15.
Elkafas, Hoda, Abdeljabar El Andaloussi, & Ayman Al‐Hendy. (2017). Emergence of uterine fibroid driver mutations in perturbed myometrial stem cells: the role ofhypovitaminosis D. Fertility and Sterility. 108(3). e390–e390. 1 indexed citations
16.
Elkafas, Hoda, et al.. (2017). Origin of Uterine Fibroids: Conversion of Myometrial Stem Cells to Tumor-Initiating Cells. Seminars in Reproductive Medicine. 35(6). 481–486. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026